Abstract View

Author(s): Ramza Rahat Hashmi 1*1, Kaushal Kumar 22, Dr. Vivek Chauhan 33

Email(s): 1ramzarahat2017@gmail.com

Address:

    1. IIMT College of Pharmacy, Greater Noida. 2. Dr. Om Prakash School of Pharmacy, Farukabad. 3. Accurate College of Pharmacy, Greater Noida.

Published In:   Volume - 2,      Issue - 1,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
: In case of oral administration, solubility is a key factor to demonstrate the pharmacological response in achieving the desired bioavailability of drugs. But most of the time, due to dissolution as the rate-limiting step intended for absorption of poorly aqueous soluble drugs (BCS Class-II and IV), it becomes challenging to formulate conventional dosage forms of such drugs. Different perspectives have been extensively inspected to improve the aqueous solubility and poor dissolution rate of BCS Class-II and Class-IV drugs such as micronisation, self-emulsification, pH-changing solubilization, salt formation, co-solvent, solid dispersion and hydrotropic use etc. Solubility and dissolution are the central principles of any physical or chemical science including biopharmaceutic and pharmacokinetic aspects in therapy with any medication. This analysis summarizes the use of hydrotropy, which is one of the promising practice for boosting solubility in several folds by adding surplus quantity of Hydrophilic solute to improve the aqueous solubility of the primary solute without any chemical alteration of the drug compound e.g. Urea, Niacinamide , Sodium salicylate, Sodium Citrate, etc. It has several advantages like it does not need organic solvent or establishment of the emulsion system.

Cite this article:
Ramza Rahat Hashmi, Kaushal Kumar, Dr. Vivek Chauhan. Formulation and Evaluation of Controlled Release Tablets of Carvedilol using Hydrotropic Technique. IJRPAS, Jan-Feb 2023; 2(1): 5-16.


1.            Sandhiya jatwani, et al. “ An Overview On Solubility Enhancement Techniques For Poorly Soluble Drugs And Solid Dispersion As An Eminent Strategic Approach” IJPSR, 2012;vol.3(4):942-956.

2.             C.V.S. Subramanyum, “ Text of biopharmaceutics and pharmacokinetics” published by vallabhprakashan, first edition-2010,page no. 171-173.

3.             Martin Alfred, et al. “ physical pharmacy” 3rd edition, published by Varghese publishing house, 1991 page no. 272-273.

4.            Michael E. Aulton, “ Aulton’s pharmaceutics the design and manufacture of medicines” pubilished by Churchill livingstone Elsevier, third edition, page no. 22-23.

5.            Jinal N. Patel, et al. 2012, “Techniques to improve the solubility of poorly soluble drugs” IJPLS, Vol. 3, Issue 2: Feb.: 2012, 1459-1469.

6.            Swati Aggarwal, et al , “Solubility And Its Enhancement Techniques Of Poorly Soluble Drugs” international journal of universal pharmacy and life sciences, 2012, (ISSN): 2249-6793

7.            Ahmad Zaheer, et al, “Solubility Enhancement Of Poorly Water Soluble Drugs: A Review” IJPT | March-2011 | Vol. 3 | Issue No.1 | 807-823

8.            D. Akhilesh, et al, “ enhacement of solubility by complexation with cyclodextrin and       nanocrystallation” I RJP 2012,3(5)

9.            Gulshan Chhabra, et al, “enhancement of solubility and dissolution rate of a poorly water soluble drug using single and double hydrophilization approach”int j pharm pharm sci, vol 4, issue 1, 395-405.

10.        Sushama Talegaonkar,et al, “Microemulsions: A Novel Approach to Enhanced Drug Delivery” Recent Patents on Drug Delivery & Formulation 2008, 2, 238-257

11.         Jyotsana Madan, et al; “Emulsion based drug delivery system” Indian Journal of Novel Drug delivery 3(1), Jan-Mar, 2011, 2-8.

12.         Aungst, B. J. (1993). Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. Journal of pharmaceutical sciences, 82(10), 979-987.

13.        Burcham, D. L., Maurin, M. B., Hausner, E. A., & Huang, S. M. (1997).Improved oral bioavailability of the hypocholesterolemic DMP 565 in dog following oral dosing in oil and glycol solutions. Biopharmaceutics & drug disposition, 18(8), 737-742

14.        Liu, R. (2000). Water-insoluble drug formulation. CRC press.

15.         Gong, Y., Grant, D. J., & Brittain, H. G. (2007). Principles of solubility.In Solvent systems and their selection in pharmaceutics and biopharmaceutics (pp. 1-27). Springer, New York, NY.

16.         Letcher, T. M. (Ed.). (2007). Thermodynamics, solubility and environmental issues. Elsevier.

17.        Raut, N. A. (2018). Enhancement of aqueous solubility and permeability of poorly water soluble drug. Pharma Focus Asia, Issue, (29).

18.         Moore, M. D., & Wildfong, P. L. (2009). Aqueous solubility enhancement through engineering of binary solid composites: pharmaceutical applications. Journal of Pharmaceutical Innovation, 4(1), 36-49.

19.        Sachan, N. K., Bhattacharya, A., Pushkar, S., & Mishra, A. (2014).

20.        Biopharmaceutical classification system: A strategic tool for oral drug delivery technology. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm, 3(2)

21.        Solubility,Wikipedia,the free encyclopedia,science daily/solubility.htm 10. Martin, A. (1993). Physical pharmacy: physical chemical principles in the pharmaceutical sciences. BI Waverly. Pvt Ltd.

22.         Gibson, M. (2001). Pharmaceutical preformulation and formulation. Drugs and the pharmaceutical sciences, 199, 199.

23.         Pharmacopoeia, I. (1996). Government of India, ministry of health and family welfare. Delhi: Controller of Publications, 2(35), 448.

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags